Literature DB >> 10356291

Sodium-dependent uptake of [3H]scyllo-inositol by Tetrahymena: incorporation into phosphatidylinositol, phosphatidylinositol-linked glycans, and polyphosphoinositols.

P E Ryals1, M C Kersting.   

Abstract

[3H]Scyllo-inositol was taken up by Tetrahymena cells through a sodium-dependent pathway wherein unlabeled scyllo- and myo-inositol competed for uptake. d-Glucose was a competitor of [3H]myo-inositol uptake, but did not appear to compete for [3H]scyllo-inositol uptake. Transport of [3H]scyllo- and [3H]myo-inositol was inhibited when sodium was removed from the labeling buffer and by phlorizin, an inhibitor of sodium-dependent transporters. Cytochalasin B, an inhibitor of facilitated glucose transporters, had no significant effect on inositol transport. Internalized [3H]scyllo-inositol was readily incorporated intact into phosphatidylinositol, phosphatidylinositol-linked glycans, and polyphosphoinositols. Distribution of [3H]scyllo- and [3H]myo-inositol radioactivity into individual polyphosphoinositols was found to differ. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10356291     DOI: 10.1006/abbi.1999.1211

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

Review 1.  Conservation and innovation in Tetrahymena membrane traffic: proteins, lipids, and compartments.

Authors:  Alejandro D Nusblat; Lydia J Bright; Aaron P Turkewitz
Journal:  Methods Cell Biol       Date:  2012       Impact factor: 1.441

2.  Trans-cyclization of phosphatidylinositol catalyzed by phospholipase C from Streptomyces antibioticus.

Authors:  Chuan Bai; Li Zhao; Mario Rebecchi; Ming-Daw Tsai; Karol S Bruzik
Journal:  J Am Chem Soc       Date:  2009-06-24       Impact factor: 15.419

3.  Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.

Authors:  Daniela Fenili; Mary Brown; Rebecca Rappaport; JoAnne McLaurin
Journal:  J Mol Med (Berl)       Date:  2007-02-06       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.